Rebalix
Logo InvescoInvesco · sheet of 5 September 2026
ETF sheet · official issuer and register data

Invesco S&P 500 Equal Weight UCITS ETF Dist

SPES · IE00BM8QRY62 · class Dist · USD · domicile Ireland
Equity · United States · Large cap · Risk paritySFDR art. 6
Index tracked: S&P 500 Equal Weight Net Total Return
TER
0.20%+ trans. 0.01%
Fund size
1.5 bn EUR
Tracking difference
+0.12%3-year avg
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical
Income
Distributingquarterly
Launch 6 Apr 2021 · costs from the KID as of 14 Aug 2026 · 504 securities held · 8 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 14 Aug 2026
Investment objective: The objective of the Fund is to achieve the net total return performance of the S&P 500 Equal Weight Index (the "Index"), less fees, expenses and transaction costs. Intended Retail Investor The Fund is intended for investors aiming for income and long term capital growth, who may not have specific financial expertise but are able to make an informed investment decision based on this document, the supplement, and the prospectus, have a risk appetite consistent with the risk indicator displayed below and understand that there is no…

Performance since series start (in euro) — base 100

6 Apr 20211 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
2022202320242025202616998165
High 169 (14 Aug 2026) · low 98 (12 May 2021) · last 165. Past performance is not indicative of future results.

Returns in euro

1 year+17.7%
3 years+40.9%
5 years+52.4%
10 yearsseries too young
Since series start+64.8%

Risk · 1 / 3 / 5 years

Volatility (ann.)11.56%13.90%16.23%
Max drawdown−8.21%−18.45%−22.52%
Sharpe1.300.790.35
Sortino1.921.150.49
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · SPES · IE00BM8QRY621
RebalixSPES · IE00BM8QRY62 · sheet of 5 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+10.91%+10.80%+0.11%
2024+12.48%+12.37%+0.11%
2023+13.32%+13.17%+0.14%
2022−11.84%−11.95%+0.11%

Distributions · per share, in USD

Frequency: quarterly · last 12 months: 0.8718 USD (1.25% of NAV) · last ex-date 10 Sept 2026
YearPaymentsTotal (USD)Dividend yield
202630.6569
202540.8333+1.50%
202440.7734+1.54%
202340.7354+1.64%
202240.6807+1.32%
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 504 securities · top-10 weight = 3.2%
Top holdingsWeight
MODERNA INC USD0.00010.6%
VEEVA SYSTEMS INC-CLASS A USD0.000010.3%
ZEBRA TECHNOLOGIES CORP-CL A USD0.010.3%
CHARLES RIVER LABORATORIES USD0.010.3%
SALESFORCE INC USD 0.0010.3%
DOORDASH INC - A USD NPV0.3%
MARATHON PETROLEUM CORP USD0.010.3%
WORKDAY INC-CLASS A USD0.0010.3%
GLOBAL PAYMENTS INC NPV0.3%
IQVIA HOLDINGS INC USD0.010.3%

Listing venues

ESMA register (FIRDS) and official exchange lists
SP2D · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 6 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/shar
Factsheet · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/shar
Prospectus · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/umbr
The live sheet, always up to date
rebalix.com/en/etf/IE00BM8QRY62
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · SPES · IE00BM8QRY622